Fredun Pharmaceuticals Ltd - 539730 - Shareholding for the Period Ended December 31, 2019
Fredun Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2019. For more details, kindly Click here14-01-2020
14-01-2020
Fredun Pharmaceuticals Ltd - 539730 - Statement Of Investor Complaints For The Quarter Ended December 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Priyanka ChaturvediDesignation :- Company Secretary and Compliance Officer03-01-2020
Fredun Pharmaceuticals Ltd - 539730 - Closure of Trading Window
The Trading Window for dealing in the securities of the Company will remain closed for Designated Persons and their immediate relatives with effect from Wednesday, January 1, 2019 till 48 hours after the end of the Board Meeting wherein; the approval of the Un-Audited Financial Results for the Quarter and Nine months ended December 31, 2019; would be considered, approved and declared.28-12-2019
Fredun Pharmaceuticals Ltd - 539730 - Consideration Of General Matters
In compliance to Regulation 30 of SEBI Listing Regulations, 2015; we wish to inform you that the Board of Directors of Fredun Pharmaceuticals Limited (hereinafter referred to as 'the Company'), at their Meeting held on Thursday, December 26, 2019; had considered and approved the Cost Audit Report and discussed the other General Matters related to the Company.26-12-2019
Fredun Pharmaceuticals Ltd - 539730 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on December 05, 2019 for Daulat Medhora05-12-2019
Fredun Pharmaceuticals Ltd - 539730 - Approved Un-Audited Financial Results For Quarter And Half Year Ended September 30, 2019
In reference to our submissions dated November 11, 2019; we resubmit the Un-Audited Financial Results of the Company and the Cash Flow Statement for the Quarter and Half Year ended September 30, 2019; along with the Limited Review Report as issued by M/s. Savla & Associates; Statutory Auditors of the Company.04-12-2019
Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Newspaper Publication
We enclose herewith the copies of the Newspaper cuttings of the Financials Results of the Company for the Quarter and Half Year ended September 2019; as approved by the Board in its Meeting held on Monday, November 11, 2019; published in Business Standard & Mumbai Lakshadeep newspaper(s) on November 13, 2019.13-11-2019
Fredun Pharmaceuticals Ltd - 539730 - Unaudited Financial Results For Quarter And Half Year Ended September 30, 2019
Board of Directors of Fredun Pharmaceuticals Limited at their Meeting held on Monday, November 11, 2019; had. considered and approved the Unaudited Financial Results for Quarter and Half Year ended September 30, 2019.11-11-2019
Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Newspaper Publication
We enclose herewith the copies of the Notice advertisement published in Business Standard & Mumbai Lakshadeep newspapers on November 4, 2019 regarding the proposed Transfer of 900 Equity Shares of the Company as per Old Transfer Deed 7B.04-11-2019
Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Newspaper Publication
We enclose herewith the copies of the Notice of the ensuing Board Meeting of the Company scheduled to be held on Monday, November 11, 2019 at 3:00 P.M.; published in Business Standard & Mumbai Lakshadeep newspapers on November 2, 2019.02-11-2019